Immunhistochemical analysis of RUNX3 expression in breast cancer and RUNX3 characterization in TNBC cell lines
Geburtshilfe und Frauenheilkunde · 01.10.2024 · 84 (10) · e136
DOI: 10.1055/s-0044-1790742 ↗Kurz gefasst
Fachartikel in der Zeitschrift Geburtshilfe und Frauenheilkunde, erschienen am 01.10.2024. Verfasst von A. Wendt und 8 weiteren Autor:innen.
Abstract (Originalsprache)
Background
The transcription factor RUNX3 is involved in cell proliferation and differentiation. The function in breast cancer and its contribution to carcinogenic phenotypes and the disease outcome is not well described. Thus, we aimed to analyze the protein expression of RUNX3 in clinical samples and analyzed the phenotypic consequences of gene expression modulation in TNBC cell lines.
Methods
Immunhistochemical staining for n=142 breast cancer cases was conducted with the Dako Real Envision HRP system using antibodies against ERa, ERb, PR, Her2, Ki67 und RUNX3. TNBC cell lines (HCC1806, HCC1143 and MDA-MB-231) were transduced to overexpress (MDA-MB-231, HCC1143) or silence RUNX3 (HCC1806, HCC1143). Cells were analyzed for cell death and cell cycle distribution (FACS), colony formation capacity, and chemo-sensitivity (MTT assay, FACS).
Results
RUNX3 protein expression in tumor cells was detected in the minority of cases (n=29, 20.4%). However, nearly one third of the basal breast cancer cases expressed RUNX3 (n=26 of 84 cases, 31%). In-vitro characterization revealed reduced colony formation, cell cycle aberrations and an influence on chemosensitivity after modulation of RUNX3 gene expression.
Discussion
RUNX3 expressing tumors are enriched in the basal/TNBC subtype and the modulation of RUNX3 expression influences tumor characteristics of TNBC cell lines. The prognostic effect of RUNX3 protein expression in TNBC is presently determined. Publication History Article published online: 01 October 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Wendt, A., Türe, M., Kroll, L., Atweh, N., Komor, O., Munzert, F., Bokhua, D., Runnebaum, I. B., & Häfner, N. (2024). Immunhistochemical analysis of RUNX3 expression in breast cancer and RUNX3 characterization in TNBC cell lines. Geburtshilfe und Frauenheilkunde, 84(10), e136. https://doi.org/10.1055/s-0044-1790742
Vancouver
Wendt A, Türe M, Kroll L, Atweh N, Komor O, Munzert F, et al. Immunhistochemical analysis of RUNX3 expression in breast cancer and RUNX3 characterization in TNBC cell lines. Geburtshilfe und Frauenheilkunde. 2024;84(10):e136. doi:10.1055/s-0044-1790742
BibTeX
@article{Wendt2024,
author = {Wendt, A. and Türe, M. and Kroll, L. and Atweh, N. and Komor, O. and Munzert, F. and Bokhua, D. and Runnebaum, I. B. and Häfner, N.},
title = {Immunhistochemical analysis of RUNX3 expression in breast cancer and RUNX3 characterization in TNBC cell lines},
journal = {Geburtshilfe und Frauenheilkunde},
year = {2024},
volume = {84},
number = {10},
pages = {e136},
doi = {10.1055/s-0044-1790742}
}
EUVIMED